Both in Pharmaceuticals
Janux Therapeutics vs Savara
Over the past year JANX returned −29.3% and SVRA returned +44.5%; their daily moves had a correlation of 0.22.
JANX −29.3% SVRA +44.5%Growth of $1, one year, split-adjusted
| Metric | JANX | SVRA |
|---|---|---|
| Price | $17.28 | $5.16 |
| Market cap | $1.06B | $1.06B |
| Today | +1.95% | +1.57% |
| 1 month | −5.2% | −4.3% |
| 6 months | +24.3% | −5.5% |
| Year to date | +25.2% | −14.4% |
| 1 year | −27.1% | +46.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −214.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 44.0× | — |
| Net cash | $970.9M | $142.9M |
| Dividend yield | — | — |
| Volatility (60d) | 45.6% | 44.2% |
| Short % of float | 13.8% | 30.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).